{"log_id": 9156080729855416098, "direction": 0, "words_result_num": 153, "words_result": [{"probability": {"variance": 0.001014, "average": 0.991328, "min": 0.819455}, "location": {"width": 482, "top": 60, "height": 24, "left": 123}, "words": "度,对儿童患者建议使用较低剂量,尤其是6-12岁体重较轻的儿童"}, {"probability": {"variance": 0.002772, "average": 0.975024, "min": 0.760687}, "location": {"width": 486, "top": 61, "height": 27, "left": 663}, "words": "不适(如恶心和呕吐)、心动过速、震颤、激动和头晕。罕有昏迷报道"}, {"probability": {"variance": 1e-05, "average": 0.997897, "min": 0.992395}, "location": {"width": 62, "top": 84, "height": 22, "left": 144}, "words": "老年用药"}, {"probability": {"variance": 0.000263, "average": 0.994958, "min": 0.914858}, "location": {"width": 493, "top": 86, "height": 24, "left": 664}, "words": "舍曲林没有特效的解毒剂。开放并保持气道通畅确保充分的供氧及"}, {"probability": {"variance": 0.000133, "average": 0.994212, "min": 0.955402}, "location": {"width": 461, "top": 106, "height": 22, "left": 159}, "words": "老年患者用药剂量范围与年轻患者的相同。共700多老年患"}, {"probability": {"variance": 0.002388, "average": 0.984981, "min": 0.729053}, "location": {"width": 483, "top": 108, "height": 25, "left": 663}, "words": "换气。可与导泻剂合用活性炭,可能与催吐或洗胃同样甚或更为有效"}, {"probability": {"variance": 0.002769, "average": 0.98653, "min": 0.712819}, "location": {"width": 484, "top": 129, "height": 21, "left": 125}, "words": "者(>65岁)参加了证实舍曲林在这部分人群中疗效的临床试验"}, {"probability": {"variance": 0.000138, "average": 0.996619, "min": 0.936047}, "location": {"width": 493, "top": 131, "height": 22, "left": 664}, "words": "在对症治疗及支持疗法同时,建议进行心脏及生命体征监测。由于"}, {"probability": {"variance": 0.005052, "average": 0.983457, "min": 0.63574}, "location": {"width": 426, "top": 151, "height": 22, "left": 131}, "words": "兰年患者中不良反应的形式和发生率与年轻患者中的相近"}, {"probability": {"variance": 0.000914, "average": 0.991297, "min": 0.834106}, "location": {"width": 494, "top": 154, "height": 23, "left": 664}, "words": "舍曲林有较大分布容积,强迫利尿,透析,血液灌注及换血疗法均"}, {"probability": {"variance": 3e-06, "average": 0.9987, "min": 0.994808}, "location": {"width": 101, "top": 175, "height": 17, "left": 139}, "words": "药物相互作用"}, {"probability": {"variance": 0.005314, "average": 0.96671, "min": 0.803716}, "location": {"width": 101, "top": 177, "height": 20, "left": 664}, "words": "没有明显意义"}, {"probability": {"variance": 0.00134, "average": 0.978531, "min": 0.855026}, "location": {"width": 449, "top": 193, "height": 25, "left": 158}, "words": "单胺氧化酶抑制剂( MAOIS):舍曲林合并单胺氧化酶抑制剂,"}, {"probability": {"variance": 3e-06, "average": 0.997964, "min": 0.995336}, "location": {"width": 70, "top": 201, "height": 19, "left": 677}, "words": "药理毒理"}, {"probability": {"variance": 0.000185, "average": 0.994655, "min": 0.931041}, "location": {"width": 498, "top": 217, "height": 24, "left": 123}, "words": "包括选择性的单胺氧化酶抑制剂司来吉兰和可逆性的单胺氧化酶抑"}, {"probability": {"variance": 2e-05, "average": 0.996476, "min": 0.988729}, "location": {"width": 66, "top": 224, "height": 18, "left": 664}, "words": "药理作用"}, {"probability": {"variance": 5.4e-05, "average": 0.995719, "min": 0.970282}, "location": {"width": 491, "top": 239, "height": 26, "left": 123}, "words": "制剂吗氯贝胺治疗出现了严重反应,有时是致命的。有些病例是"}, {"probability": {"variance": 0.011282, "average": 0.974716, "min": 0.423773}, "location": {"width": 460, "top": 245, "height": 26, "left": 696}, "words": "盐酸舍曲林是一种选择性5羟色胺再摄取抑制剂。其作用机制"}, {"probability": {"variance": 0.011165, "average": 0.971166, "min": 0.48843}, "location": {"width": 498, "top": 261, "height": 26, "left": 123}, "words": "似5-羟色胺综合症的表现,包括:发热、强直、肌肉痉挛、自主神"}, {"probability": {"variance": 0.00452, "average": 0.983777, "min": 0.62329}, "location": {"width": 492, "top": 267, "height": 26, "left": 664}, "words": "与其对中枢神经元5-羟色胺再摄取的抑制有关。在临床剂量下,舍"}, {"probability": {"variance": 0.003574, "average": 0.983616, "min": 0.696362}, "location": {"width": 483, "top": 285, "height": 22, "left": 121}, "words": "经功能紊乱伴生命体征快速波动:精神状况的改变包括精神紊乱"}, {"probability": {"variance": 0.001877, "average": 0.986918, "min": 0.766035}, "location": {"width": 494, "top": 289, "height": 28, "left": 663}, "words": "曲林阻断人类血小板对5-羟色胺的摄取。研究提示舍曲林是一种强"}, {"probability": {"variance": 0.003138, "average": 0.978805, "min": 0.724593}, "location": {"width": 496, "top": 307, "height": 23, "left": 123}, "words": "易激惹及极度激越直至发展为谵妄和昏迷。所以,服用单胺氧化酶"}, {"probability": {"variance": 3.6e-05, "average": 0.996117, "min": 0.976163}, "location": {"width": 498, "top": 327, "height": 27, "left": 123}, "words": "抑制剂或停用单胺氧化酶抑制剂14天内不能服用本药;同样,舍曲"}, {"probability": {"variance": 0.001029, "average": 0.992256, "min": 0.820284}, "location": {"width": 494, "top": 313, "height": 25, "left": 663}, "words": "效和选择性的神经元5-羟色胺再摄取抑制剂,对去甲肾上腺素和多"}, {"probability": {"variance": 0.001696, "average": 0.987442, "min": 0.786431}, "location": {"width": 450, "top": 337, "height": 23, "left": 661}, "words": "巴胺仅有微弱影响。体外研究显示,舍曲林对肾上腺素能受体"}, {"probability": {"variance": 0.0003, "average": 0.995706, "min": 0.909244}, "location": {"width": 427, "top": 351, "height": 23, "left": 123}, "words": "林停药后也需14天以上才能开始单胺氧化酶抑制剂的治疗"}, {"probability": {"variance": 0.000188, "average": 0.993328, "min": 0.936323}, "location": {"width": 463, "top": 370, "height": 29, "left": 158}, "words": "中枢神经系统抑制剂和酒精:每日同时服用舍曲林200mg,不"}, {"probability": {"variance": 0.005729, "average": 0.974359, "min": 0.717905}, "location": {"width": 386, "top": 359, "height": 24, "left": 740}, "words": "胆碱能受体、GABA受体、多巴胺能受体、组胺受体"}, {"probability": {"variance": 0.006817, "average": 0.975655, "min": 0.662134}, "location": {"width": 492, "top": 393, "height": 26, "left": 124}, "words": "会增加乙醇、卡马西平、氟哌啶醇或苯妥英对健康受试者认知功能"}, {"probability": {"variance": 0.008828, "average": 0.970983, "min": 0.447616}, "location": {"width": 493, "top": 380, "height": 25, "left": 663}, "words": "羟色胺受体(5HTA、5HTIB、5HT3)或苯二氮卓类受体没有明显的"}, {"probability": {"variance": 3e-06, "average": 0.998722, "min": 0.992057}, "location": {"width": 433, "top": 417, "height": 22, "left": 125}, "words": "和精神运动性活动能力的作用,但不主张舍曲林与酒精合用"}, {"probability": {"variance": 0.005523, "average": 0.977586, "min": 0.600712}, "location": {"width": 490, "top": 402, "height": 26, "left": 663}, "words": "亲和力。对上述受体的拮抗作用被认为与其他精神疾病用药的镇静"}, {"probability": {"variance": 4e-06, "average": 0.998642, "min": 0.99092}, "location": {"width": 464, "top": 438, "height": 24, "left": 156}, "words": "锂剂:对正常志愿者进行的安慰剂对照试验中,舍曲林与锂剂"}, {"probability": {"variance": 6.8e-05, "average": 0.996374, "min": 0.959447}, "location": {"width": 496, "top": 425, "height": 23, "left": 661}, "words": "作用、抗胆碱作用和心脏毒性相关。动物长期给予舍曲林可使脑中"}, {"probability": {"variance": 0.000109, "average": 0.996087, "min": 0.945437}, "location": {"width": 481, "top": 460, "height": 22, "left": 123}, "words": "合用未明显改变锂剂的药代动力学参数,但与安慰剂相比震颤增多"}, {"probability": {"variance": 6.3e-05, "average": 0.996125, "min": 0.963442}, "location": {"width": 477, "top": 447, "height": 25, "left": 662}, "words": "去甲肾上腺素受体下调,这与临床上其它抗抑郁症药物的作用一致"}, {"probability": {"variance": 6.6e-05, "average": 0.997124, "min": 0.957147}, "location": {"width": 496, "top": 482, "height": 23, "left": 123}, "words": "表明两药之间存在药效学相互作用的可能。舍曲林与其他经5羟色"}, {"probability": {"variance": 0.000353, "average": 0.993246, "min": 0.924373}, "location": {"width": 254, "top": 468, "height": 25, "left": 662}, "words": "舍曲林对单胺氧化酶没有抑制作用"}, {"probability": {"variance": 0.000197, "average": 0.990522, "min": 0.966252}, "location": {"width": 65, "top": 493, "height": 19, "left": 664}, "words": "毒理研究"}, {"probability": {"variance": 0.014442, "average": 0.96541, "min": 0.407878}, "location": {"width": 416, "top": 505, "height": 21, "left": 122}, "words": "能机制起作用的药物如锂剂合用时,应对病人进行监扩"}, {"probability": {"variance": 0.013562, "average": 0.961478, "min": 0.381001}, "location": {"width": 469, "top": 524, "height": 32, "left": 154}, "words": "苯妥英:在健康志愿者的安慰剂对照研究中,每日200m舍曲"}, {"probability": {"variance": 0.003609, "average": 0.98299, "min": 0.683671}, "location": {"width": 461, "top": 512, "height": 28, "left": 695}, "words": "遗传毒性:细菌突变试验、小鼠淋巴瘤突变试验、在体小鼠骨"}, {"probability": {"variance": 0.007917, "average": 0.974573, "min": 0.520505}, "location": {"width": 491, "top": 548, "height": 25, "left": 121}, "words": "林长期服药并不显著地抑制苯妥英的代谢。然而,如需与舍曲林合用"}, {"probability": {"variance": 3e-06, "average": 0.998199, "min": 0.991992}, "location": {"width": 496, "top": 536, "height": 27, "left": 660}, "words": "髓和体外人淋巴细胞遗传学试验结果表明,在有或无代谢激活存在"}, {"probability": {"variance": 8.7e-05, "average": 0.995212, "min": 0.953656}, "location": {"width": 501, "top": 569, "height": 28, "left": 120}, "words": "在开始加用舍曲林时应当监测苯妥英的血药浓度,同时适当调整苯"}, {"probability": {"variance": 3e-06, "average": 0.998519, "min": 0.993845}, "location": {"width": 220, "top": 560, "height": 19, "left": 659}, "words": "时,舍曲林均未出现遗传毒性"}, {"probability": {"variance": 2e-06, "average": 0.998379, "min": 0.995923}, "location": {"width": 175, "top": 580, "height": 23, "left": 694}, "words": "生殖毒性:给药剂量为"}, {"probability": {"variance": 0.000204, "average": 0.989421, "min": 0.961261}, "location": {"width": 78, "top": 595, "height": 19, "left": 123}, "words": "妥英的剂量"}, {"probability": {"variance": 0.000134, "average": 0.994658, "min": 0.949677}, "location": {"width": 239, "top": 584, "height": 21, "left": 917}, "words": "kg(以mg/m2计,为人最大推荐"}, {"probability": {"variance": 0.005667, "average": 0.981584, "min": 0.598952}, "location": {"width": 465, "top": 614, "height": 23, "left": 154}, "words": "舒马普坦:在舍曲林上市后,有个别报道舍曲林与舒马普坦合"}, {"probability": {"variance": 0.000181, "average": 0.993658, "min": 0.935193}, "location": {"width": 488, "top": 605, "height": 21, "left": 658}, "words": "剂量MRHD的4倍)时,两个大鼠试验之一观察到动物生育力降低"}, {"probability": {"variance": 0.009746, "average": 0.974883, "min": 0.461438}, "location": {"width": 496, "top": 636, "height": 24, "left": 122}, "words": "并使用后,病人出现体弱、腱反射亢进、共济失调、意识模糊、焦"}, {"probability": {"variance": 0.005219, "average": 0.981815, "min": 0.551441}, "location": {"width": 493, "top": 624, "height": 28, "left": 661}, "words": "在大鼠和家兔上进行了剂量分别达80mg/ /kg/day和40mg/ Kkg/day的生"}, {"probability": {"variance": 0.007351, "average": 0.974852, "min": 0.54833}, "location": {"width": 500, "top": 656, "height": 25, "left": 121}, "words": "虑和激越。如果临床上确实需要舍曲林与该药合并使用的话,一应当"}, {"probability": {"variance": 0.000348, "average": 0.992568, "min": 0.91948}, "location": {"width": 493, "top": 648, "height": 22, "left": 661}, "words": "殖毒性研究(以mg/m2计,为人最大推荐剂量MRHD的4倍),在"}, {"probability": {"variance": 2e-05, "average": 0.996556, "min": 0.984945}, "location": {"width": 170, "top": 680, "height": 20, "left": 120}, "words": "对病人进行密切的观察"}, {"probability": {"variance": 0.000571, "average": 0.991286, "min": 0.881923}, "location": {"width": 464, "top": 700, "height": 24, "left": 155}, "words": "与蛋白结合的药物:因舍曲林与血浆蛋白结合,应注意舍曲林"}, {"probability": {"variance": 0.027829, "average": 0.905421, "min": 0.36563}, "location": {"width": 552, "top": 681, "height": 34, "left": 601}, "words": "人别给予舍曲林(剂量分别10mgkg和40mgkgmgm2计相"}, {"probability": {"variance": 0.000487, "average": 0.989955, "min": 0.909807}, "location": {"width": 496, "top": 721, "height": 26, "left": 122}, "words": "和其它与血浆蛋白结合药物之间相互作用的可能性。但是,舍曲林"}, {"probability": {"variance": 0.00525, "average": 0.972965, "min": 0.612591}, "location": {"width": 494, "top": 712, "height": 26, "left": 659}, "words": "当于MRHD的0.5倍和4倍)时观察到胎仔骨化延迟。雌性大鬣妊"}, {"probability": {"variance": 0.018222, "average": 0.956796, "min": 0.469785}, "location": {"width": 480, "top": 744, "height": 22, "left": 122}, "words": "分别与地西泮、甲苯磺丁脲和华法林相互作用的黑项正式研究电"}, {"probability": {"variance": 0.00096, "average": 0.987966, "min": 0.833403}, "location": {"width": 481, "top": 735, "height": 23, "left": 659}, "words": "娠后期及哺乳期给予舍曲林,剂量20mg/kg下死产幼鼠及出生后"}, {"probability": {"variance": 0.000807, "average": 0.991821, "min": 0.863767}, "location": {"width": 374, "top": 767, "height": 21, "left": 120}, "words": "未见舍曲林对这些药物的蛋白结合率有明显的影响"}, {"probability": {"variance": 0.001604, "average": 0.987903, "min": 0.78059}, "location": {"width": 492, "top": 755, "height": 28, "left": 661}, "words": "天幼鼠死亡数量增加,出生后前4天幼鼠的体重亦降低,对大鼠幼"}, {"probability": {"variance": 0.003521, "average": 0.984367, "min": 0.667628}, "location": {"width": 460, "top": 789, "height": 23, "left": 158}, "words": "华法林:舍曲林200mg/日与华法林联合应用在一定程度上增加"}, {"probability": {"variance": 2e-05, "average": 0.996544, "min": 0.979182}, "location": {"width": 491, "top": 779, "height": 26, "left": 661}, "words": "鼠无影响剂量为10mg/kg幼鼠存活率的降低是由舍曲林在子宫的暴"}, {"probability": {"variance": 8.9e-05, "average": 0.995995, "min": 0.950988}, "location": {"width": 499, "top": 809, "height": 26, "left": 120}, "words": "凝血酶原时间,但临床意义不明确。因此,舍曲林与华法林联合应"}, {"probability": {"variance": 0.000937, "average": 0.9905, "min": 0.86476}, "location": {"width": 303, "top": 803, "height": 21, "left": 659}, "words": "露所致。但这些作用的临床意义尚不清楚"}, {"probability": {"variance": 2e-06, "average": 0.999106, "min": 0.994964}, "location": {"width": 269, "top": 832, "height": 21, "left": 120}, "words": "用或停用时应密切监测凝血酶原时间"}, {"probability": {"variance": 0.006964, "average": 0.974224, "min": 0.604687}, "location": {"width": 460, "top": 825, "height": 24, "left": 693}, "words": "致癌性:在CD-1小鼠和 long-evans大鼠上进行了剂量达"}, {"probability": {"variance": 0.000232, "average": 0.994001, "min": 0.927719}, "location": {"width": 464, "top": 854, "height": 24, "left": 155}, "words": "与其它药物的相互作用:已进行了舍曲林与其它药物间相互作"}, {"probability": {"variance": 0.007052, "average": 0.971378, "min": 0.537188}, "location": {"width": 452, "top": 847, "height": 23, "left": 686}, "words": " Ig/kg/day(以mg/m2计,分别约相当于MRHD的1倍和2倍"}, {"probability": {"variance": 1e-05, "average": 0.997061, "min": 0.99099}, "location": {"width": 192, "top": 875, "height": 21, "left": 119}, "words": "用的研究。每日舍曲林20"}, {"probability": {"variance": 0.000539, "average": 0.988201, "min": 0.913747}, "location": {"width": 251, "top": 876, "height": 24, "left": 349}, "words": "与地西泮或甲苯磺丁脲合用可导致"}, {"probability": {"variance": 0.00046, "average": 0.990371, "min": 0.896136}, "location": {"width": 493, "top": 868, "height": 26, "left": 659}, "words": "的终生致癌性研究。在10~40mg/kg剂量时,雄性小鼠出现剂量相关"}, {"probability": {"variance": 0.000115, "average": 0.995022, "min": 0.961661}, "location": {"width": 498, "top": 896, "height": 26, "left": 119}, "words": "些药代动力学参数较小的、但有统计学意义的改变。与西咪替丁合"}, {"probability": {"variance": 0.000238, "average": 0.994904, "min": 0.914198}, "location": {"width": 492, "top": 889, "height": 28, "left": 660}, "words": "性的肝腺瘤增加,在雌性小鼠或接受相同给药处理的大鼠上未观察"}, {"probability": {"variance": 0.000232, "average": 0.993709, "min": 0.923295}, "location": {"width": 497, "top": 919, "height": 22, "left": 121}, "words": "用可明显降低舍曲林的消除。这些改变的临床意义尚不明确。舍曲"}, {"probability": {"variance": 0.009216, "average": 0.965799, "min": 0.613143}, "location": {"width": 489, "top": 914, "height": 22, "left": 663}, "words": "到肝腺瘤的增加。CD1小鼠肝腺瘤的自发率具有波动性,该结果对"}, {"probability": {"variance": 0.000409, "average": 0.990052, "min": 0.940656}, "location": {"width": 118, "top": 942, "height": 19, "left": 120}, "words": "林对阿替洛尔的"}, {"probability": {"variance": 0.001163, "average": 0.98766, "min": 0.845092}, "location": {"width": 345, "top": 941, "height": 23, "left": 273}, "words": "肾上腺素能阻滞作用无任何影响。每日舍曲林"}, {"probability": {"variance": 0.000237, "average": 0.992425, "min": 0.937466}, "location": {"width": 478, "top": 933, "height": 28, "left": 660}, "words": "人类的意义尚不清楚。40mg/kg雌性大鼠出现甲状腺滤泡腺瘤增加"}, {"probability": {"variance": 6e-05, "average": 0.995072, "min": 0.972764}, "location": {"width": 319, "top": 963, "height": 20, "left": 120}, "words": "200mg与格列本脲或地高辛之间无相互作用"}, {"probability": {"variance": 0.000439, "average": 0.990778, "min": 0.902704}, "location": {"width": 491, "top": 955, "height": 28, "left": 662}, "words": "同时并不伴有甲状腺增生。与对照组比较,10~40mg/kg给药组大鼠"}, {"probability": {"variance": 0.012622, "average": 0.96579, "min": 0.510436}, "location": {"width": 465, "top": 985, "height": 25, "left": 154}, "words": "电体克治疗(ECT):尚无考察舍曲林与电体克治疗合用优点"}, {"probability": {"variance": 0.000519, "average": 0.988501, "min": 0.896444}, "location": {"width": 364, "top": 979, "height": 21, "left": 663}, "words": "子宫腺瘤增加,但尚不明确该结果与药物的相关性"}, {"probability": {"variance": 5e-06, "average": 0.997529, "min": 0.99394}, "location": {"width": 166, "top": 1007, "height": 20, "left": 121}, "words": "或危险方面的临床试验"}, {"probability": {"variance": 0.00063, "average": 0.985396, "min": 0.88758}, "location": {"width": 463, "top": 999, "height": 28, "left": 691}, "words": "依赖性:动物研究未显示本品有兴奋作用或巴比妥样(中枢抑"}, {"probability": {"variance": 0.000728, "average": 0.990238, "min": 0.848518}, "location": {"width": 466, "top": 1029, "height": 23, "left": 152}, "words": "细胞色素P450(CYP)2D6代谢的药物:抗抑郁药物对药物代"}, {"probability": {"variance": 0.000263, "average": 0.989217, "min": 0.946008}, "location": {"width": 152, "top": 1022, "height": 22, "left": 657}, "words": "制剂)滥用的潜在性"}, {"probability": {"variance": 4e-05, "average": 0.996286, "min": 0.966009}, "location": {"width": 492, "top": 1050, "height": 21, "left": 122}, "words": "谢同功酶CYP2D6的抑制作用程度是不尽相同的。其临床意义需取"}, {"probability": {"variance": 1e-06, "average": 0.99896, "min": 0.997647}, "location": {"width": 97, "top": 1044, "height": 21, "left": 663}, "words": "【药代动力学"}, {"probability": {"variance": 0.017191, "average": 0.960801, "min": 0.386183}, "location": {"width": 494, "top": 1071, "height": 25, "left": 119}, "words": "于抑制作用的程度及合用药物的治疗指数。治疗指数较窄的CYF"}, {"probability": {"variance": 0.000532, "average": 0.990281, "min": 0.897367}, "location": {"width": 459, "top": 1066, "height": 25, "left": 693}, "words": "舍曲林主要通过肝脏代谢,其半衰期约为24小时。血浆中的主"}, {"probability": {"variance": 3e-06, "average": 0.99851, "min": 0.994214}, "location": {"width": 205, "top": 1092, "height": 22, "left": 119}, "words": "2D6底物,包括普罗帕酮"}, {"probability": {"variance": 0.000381, "average": 0.982239, "min": 0.955877}, "location": {"width": 136, "top": 1096, "height": 19, "left": 462}, "words": "氟瓜尼( flecainide"}, {"probability": {"variance": 0.010075, "average": 0.978427, "min": 0.420353}, "location": {"width": 490, "top": 1088, "height": 26, "left": 659}, "words": "要代谢产物去甲基舍曲林,半衰期62104小时,体外试验显示其药"}, {"probability": {"variance": 0.000707, "average": 0.990335, "min": 0.893882}, "location": {"width": 500, "top": 1117, "height": 21, "left": 118}, "words": "在内的三环类抗抑郁药物和IC类抗心律失常药物。已有的药物"}, {"probability": {"variance": 0.005411, "average": 0.980246, "min": 0.587924}, "location": {"width": 492, "top": 1112, "height": 23, "left": 660}, "words": "理活性明显低于舍曲林,约是舍曲林的120。没有证据表明去甲基"}, {"probability": {"variance": 1.4e-05, "average": 0.998017, "min": 0.986342}, "location": {"width": 212, "top": 1138, "height": 20, "left": 119}, "words": "相互作用的研究表明,每日"}, {"probability": {"variance": 2.4e-05, "average": 0.995136, "min": 0.98577}, "location": {"width": 231, "top": 1139, "height": 20, "left": 383}, "words": "舍曲林长期给药可使地西帕明"}, {"probability": {"variance": 4.4e-05, "average": 0.994735, "min": 0.975303}, "location": {"width": 494, "top": 1134, "height": 22, "left": 658}, "words": "舍曲林在抑郁模型体内有药理活性。舍曲林和去甲基舍曲林在人体"}, {"probability": {"variance": 0.0013, "average": 0.986135, "min": 0.844762}, "location": {"width": 382, "top": 1161, "height": 20, "left": 236}, "words": "CYP2D6同功酶活性的标志物)稳态的血药浓度轻"}, {"probability": {"variance": 0.00035, "average": 0.994417, "min": 0.896694}, "location": {"width": 492, "top": 1155, "height": 23, "left": 659}, "words": "内大部分被代谢,其最终代谢产物从粪便和尿中等量排泄,只有少"}, {"probability": {"variance": 0.00382, "average": 0.961929, "min": 0.817254}, "location": {"width": 139, "top": 1181, "height": 20, "left": 123}, "words": "度增加(平均30-40"}, {"probability": {"variance": 0.000582, "average": 0.984233, "min": 0.911894}, "location": {"width": 290, "top": 1177, "height": 21, "left": 658}, "words": "量舍曲林(<0.2%)以原形从尿中排出"}, {"probability": {"variance": 0.000274, "average": 0.991974, "min": 0.909967}, "location": {"width": 434, "top": 1203, "height": 21, "left": 152}, "words": "其他细胞色素(CYP)酶代谢的药物(CYP3A/4,CYP2"}, {"probability": {"variance": 0.000151, "average": 0.994478, "min": 0.95037}, "location": {"width": 460, "top": 1197, "height": 27, "left": 693}, "words": "舍曲林的血药浓度随剂量改变成比例变化:并且不受年龄的影"}, {"probability": {"variance": 0.002493, "average": 0.959002, "min": 0.888715}, "location": {"width": 122, "top": 1226, "height": 17, "left": 117}, "words": " CYP2C19, CYP"}, {"probability": {"variance": 0.016272, "average": 0.95969, "min": 0.453522}, "location": {"width": 281, "top": 1221, "height": 20, "left": 658}, "words": "喲。在男性,舍曲林每日口服一次50"}, {"probability": {"variance": 3.7e-05, "average": 0.995884, "min": 0.981372}, "location": {"width": 129, "top": 1224, "height": 18, "left": 1008}, "words": "连续用药14天后"}, {"probability": {"variance": 0, "average": 0.999345, "min": 0.999345}, "location": {"width": 18, "top": 1250, "height": 13, "left": 160}, "words": "Y"}, {"probability": {"variance": 5.7e-05, "average": 0.997581, "min": 0.964988}, "location": {"width": 443, "top": 1242, "height": 26, "left": 251}, "words": "体内药物相互作用试验表明长期服用舍曲林服药"}, {"probability": {"variance": 0.000762, "average": 0.987781, "min": 0.893941}, "location": {"width": 397, "top": 1244, "height": 21, "left": 755}, "words": "小时人体血药浓度达峰值(Cmx)。青少年和老年人的"}, {"probability": {"variance": 0.003394, "average": 0.983478, "min": 0.70251}, "location": {"width": 498, "top": 1268, "height": 20, "left": 119}, "words": "200mg/日不会对CYP3A3/4介导的内生皮质醇的羟化或卡马西平及"}, {"probability": {"variance": 0.00016, "average": 0.995418, "min": 0.929388}, "location": {"width": 479, "top": 1264, "height": 24, "left": 658}, "words": "药代动力学曲线与18~65岁之间成人无明显差别。青年人和老年人"}, {"probability": {"variance": 1.7e-05, "average": 0.997475, "min": 0.979166}, "location": {"width": 499, "top": 1288, "height": 21, "left": 118}, "words": "特非那定的代谢产生抑制作用。另外,每日50mg舍曲林长期给药"}, {"probability": {"variance": 0.004568, "average": 0.976587, "min": 0.699771}, "location": {"width": 494, "top": 1285, "height": 25, "left": 658}, "words": "男性和女性的舍曲林平均半衰期平均为22-36小时。与终末消除半"}, {"probability": {"variance": 0.000657, "average": 0.989935, "min": 0.81548}, "location": {"width": 1029, "top": 1307, "height": 26, "left": 123}, "words": "不会对CYP3A34介导的阿普唑伦药物代谢产生抑制作用。这说明衰期相一致,每天给药一次,一星期达稳态浓度,在这过程中有两"}, {"probability": {"variance": 0.000807, "average": 0.985306, "min": 0.906677}, "location": {"width": 237, "top": 1332, "height": 21, "left": 119}, "words": "舍曲林不是CYP3A3/4的抑制剂"}, {"probability": {"variance": 0.00775, "average": 0.97936, "min": 0.499031}, "location": {"width": 487, "top": 1331, "height": 23, "left": 658}, "words": "倍的浓度蓄积。舍曲林的血浆蛋白结合率为98%。动物试验结果表明"}, {"probability": {"variance": 0.008913, "average": 0.974816, "min": 0.458587}, "location": {"width": 465, "top": 1353, "height": 24, "left": 152}, "words": "CYP2C9:长期服用舍曲林200mg/日对甲苯磺丁脲、苯妥英和"}, {"probability": {"variance": 4e-06, "average": 0.998229, "min": 0.992046}, "location": {"width": 205, "top": 1352, "height": 21, "left": 658}, "words": "舍曲林的表观分布容积较大"}, {"probability": {"variance": 0.000143, "average": 0.993525, "min": 0.941297}, "location": {"width": 495, "top": 1376, "height": 24, "left": 119}, "words": "华法林的血药浓度没有明显影响。这说明舍曲林不是CYP2C9的临"}, {"probability": {"variance": 0.004832, "average": 0.973095, "min": 0.703798}, "location": {"width": 301, "top": 1374, "height": 23, "left": 692}, "words": "食物对台曲林片的生物利用度无明显影响"}, {"probability": {"variance": 1.9e-05, "average": 0.995396, "min": 0.988815}, "location": {"width": 103, "top": 1399, "height": 18, "left": 117}, "words": "床相关抑制剂"}, {"probability": {"variance": 2e-06, "average": 0.998756, "min": 0.996578}, "location": {"width": 97, "top": 1398, "height": 17, "left": 693}, "words": "藏】密封保存"}, {"probability": {"variance": 0.001732, "average": 0.979922, "min": 0.789455}, "location": {"width": 468, "top": 1418, "height": 25, "left": 150}, "words": "CYP2C19:长期服用舍曲林200mg/日对地西泮的血药浓度无"}, {"probability": {"variance": 0.000903, "average": 0.984517, "min": 0.851031}, "location": {"width": 475, "top": 1419, "height": 25, "left": 671}, "words": "包装】铝塑包装,7片/板,1板/盒:12片/板,1板/盒;7片/板"}, {"probability": {"variance": 0.000169, "average": 0.993033, "min": 0.940646}, "location": {"width": 352, "top": 1440, "height": 23, "left": 117}, "words": "明显影响,说明舍曲林也非CYP2C19的抑制剂"}, {"probability": {"variance": 0.000866, "average": 0.978245, "min": 0.936633}, "location": {"width": 44, "top": 1441, "height": 18, "left": 670}, "words": "板/盒"}, {"probability": {"variance": 0.009565, "average": 0.970652, "min": 0.540672}, "location": {"width": 448, "top": 1463, "height": 22, "left": 159}, "words": "YPIA2:体外试验研究表明舍曲林对CYP1A2无明显抑制作用"}, {"probability": {"variance": 5e-06, "average": 0.99841, "min": 0.994431}, "location": {"width": 124, "top": 1461, "height": 22, "left": 671}, "words": "有效期】36个月"}, {"probability": {"variance": 0.000779, "average": 0.988752, "min": 0.863365}, "location": {"width": 463, "top": 1485, "height": 19, "left": 151}, "words": "其他5-羟色胺能药物:舍曲林与可增加5-羟色胺神经传导作用"}, {"probability": {"variance": 0.000475, "average": 0.990811, "min": 0.919803}, "location": {"width": 303, "top": 1484, "height": 20, "left": 671}, "words": "执行标准】《中国药典》2015年版第二部"}, {"probability": {"variance": 0.000479, "average": 0.989845, "min": 0.911713}, "location": {"width": 496, "top": 1505, "height": 22, "left": 117}, "words": "的药物如色氨酸或芬氟拉明合用时应慎重考虑,避免出现可能的药"}, {"probability": {"variance": 0.001288, "average": 0.985474, "min": 0.884188}, "location": {"width": 154, "top": 1506, "height": 19, "left": 668}, "words": "批准文号】国药准字"}, {"probability": {"variance": 1e-06, "average": 0.999036, "min": 0.997636}, "location": {"width": 99, "top": 1527, "height": 18, "left": 118}, "words": "效学相互作用"}, {"probability": {"variance": 0, "average": 0.999887, "min": 0.999707}, "location": {"width": 72, "top": 1528, "height": 17, "left": 673}, "words": "生产企业"}, {"probability": {"variance": 9e-06, "average": 0.997912, "min": 0.991399}, "location": {"width": 85, "top": 1549, "height": 18, "left": 126}, "words": "【药物过量】"}, {"probability": {"variance": 0.00018, "average": 0.994386, "min": 0.943465}, "location": {"width": 286, "top": 1548, "height": 21, "left": 690}, "words": "企业名称:万特制药(海南)有限公司"}, {"probability": {"variance": 0.000231, "average": 0.994344, "min": 0.920535}, "location": {"width": 462, "top": 1568, "height": 24, "left": 151}, "words": "有证据表明,舍曲林在过量服用后仍有很大的安全范围。曾有"}, {"probability": {"variance": 0.003018, "average": 0.985059, "min": 0.772321}, "location": {"width": 251, "top": 1569, "height": 21, "left": 689}, "words": "生产地址:海口市南海大道279号"}, {"probability": {"variance": 0.000189, "average": 0.993845, "min": 0.924294}, "location": {"width": 496, "top": 1589, "height": 22, "left": 117}, "words": "舍曲林单独过量服用高达13.5克的报道。曾有过量服用舍曲林导致"}, {"probability": {"variance": 0.03306, "average": 0.931134, "min": 0.363987}, "location": {"width": 129, "top": 1592, "height": 18, "left": 694}, "words": "政编码:570314"}, {"probability": {"variance": 4.6e-05, "average": 0.996315, "min": 0.9743}, "location": {"width": 481, "top": 1610, "height": 21, "left": 118}, "words": "死亡的报道,但大多出现于与其它药物和/或酒精联合应用情况下"}, {"probability": {"variance": 0, "average": 0.999712, "min": 0.999414}, "location": {"width": 66, "top": 1613, "height": 17, "left": 688}, "words": "电话号码"}, {"probability": {"variance": 8e-06, "average": 0.998201, "min": 0.989087}, "location": {"width": 283, "top": 1631, "height": 20, "left": 117}, "words": "因此,应对任何用药过量给予积极治疗"}, {"probability": {"variance": 5.2e-05, "average": 0.994074, "min": 0.982212}, "location": {"width": 69, "top": 1633, "height": 22, "left": 688}, "words": "传真号码"}, {"probability": {"variance": 0, "average": 0.999273, "min": 0.999134}, "location": {"width": 17, "top": 1638, "height": 17, "left": 861}, "words": "36"}, {"probability": {"variance": 0.00425, "average": 0.978452, "min": 0.669944}, "location": {"width": 467, "top": 1653, "height": 23, "left": 146}, "words": "药物过量症状包括有因5-羟色胺引起的不良反应如嗜睡、胃肠"}, {"probability": {"variance": 0.003959, "average": 0.961837, "min": 0.81327}, "location": {"width": 107, "top": 1660, "height": 19, "left": 1032}, "words": "20104版BCO5"}], "language": 3}